Zhongzhi Pharmaceutical Holdings Ltd 2023 AR2
The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance and sustainability initiatives for the fiscal year 2023. The company celebrated its 30th anniversary and recorded a 12.3% increase in revenue to RMB2,049.8 million, with profit attributable to owners rising by 53.0% to RMB162.8 million. On the sustainability front, the company advanced its quality management systems, with its testing centers maintaining CNAS accreditation. Zhongzhi Pharmaceutical also expanded its standardized plantation bases for Chinese medicine herbs, including organic certification for its Astragalus base. Additionally, the company implemented energy and water conservation programs, reducing its overall environmental footprint.
Company: Zhongzhi Pharmaceutical Holdings Ltd
Sector: Health Care
Country: China
Year: 2023
Type: AR2
Pages: 193
Zhongzhi Pharmaceutical Holdings Ltd
Annual Report
The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance and sustainability initiatives for the fiscal year 2023. The company celebrated its 30th anniversary and recorded a 12.3% increase in revenue to RMB2,049.8 million, with profit attributable to owners rising by 53.0% to RMB162.8 million. On the sustainability front, the company advanced its quality management systems, with its testing centers maintaining CNAS accreditation. Zhongzhi Pharmaceutical also expanded its standardized plantation bases for Chinese medicine herbs, including organic certification for its Astragalus base. Additionally, the company implemented energy and water conservation programs, reducing its overall environmental footprint.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women on Board
Workplace Fatalities
Employees